Chief Medical Officer · Minerva Neurosciences, Inc. (NERV)

Michael Davidson

FY2021 is the first fiscal year CompBrief holds for Michael Davidson as a named executive officer of Minerva Neurosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$657,466

Salary $399,693Bonus $257,773

3rd of 4 named executive officers at Minerva Neurosciences by FY2021 total.

4 named officers on file for Minerva Neurosciences, FY2021

Michael Davidson’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Minerva Neurosciences’s whole pay program stands against its peers

  • Minerva Neurosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NERV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2022 (DEF 14A).

Free

Get Michael Davidson’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Davidson compensation by year

Minerva Neurosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Minerva Neurosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$399,693
Bonus$257,773
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$657,466

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Minerva Neurosciences, Inc. DEF 14A filed April 26, 2022, accession 0001193125-22-120328, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Minerva Neurosciences, Inc. filed document, accession 0001193125-22-120328. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU159,596$127,677—
Option56,667—$3.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Minerva Neurosciences, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Minerva Neurosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Remy LuthringerChief Executive Officer$1,189,133
Geoffrey RacePresident$880,439
Michael Davidson · this pageChief Medical Officer$657,466
Frederick AhlholmSVP, Chief Financial Officer and Secretary$610,683

The full Minerva Neurosciences compensation record

free company brief

This page is one person within Minerva Neurosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Minerva Neurosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Davidson's compensation dossier · One-time report. No refunds.